CCM
Catalio Capital Management Portfolio holdings
AUM
$477M
This Quarter Return
+7.86%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$477M
AUM Growth
+$477M
(+18%)
Cap. Flow
+$48.4M
Cap. Flow
% of AUM
10.15%
Top 10 Holdings %
Top 10 Hldgs %
62.53%
Holding
48
New
12
Increased
8
Reduced
14
Closed
7
Top Buys
| 1 |
Gilead Sciences
GILD
|
$25.2M |
| 2 |
Boston Scientific
BSX
|
$24.6M |
| 3 |
Eli Lilly
LLY
|
$23.6M |
| 4 |
Soleno Therapeutics
SLNO
|
$20.9M |
| 5 |
Teva Pharmaceuticals
TEVA
|
$19.6M |
Top Sells
| 1 |
Becton Dickinson
BDX
|
$46.7M |
| 2 |
SWTX
SpringWorks Therapeutics
SWTX
|
$33.5M |
| 3 |
Veracyte
VCYT
|
$22.6M |
| 4 |
LivaNova
LIVN
|
$15M |
| 5 |
Inspire Medical Systems
INSP
|
$13.7M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SEPN
26
Septerna, Inc. Common Stock
SEPN
$539M
| $3.11M | 0.65% |
294,360
-729,885
| -71% | -$7.71M |
|
27
Replimune Group
REPL
$461M
| $3.07M | 0.64% |
330,337
-25,303
| -7% | -$235K |
|
|
ZBIO
28
Zenas BioPharma, Inc. Common Stock
ZBIO
$674M
| $2.09M | 0.44% |
215,314
-79,834
| -27% | -$774K |
|
29
Vir Biotechnology
VIR
$695M
| $1.96M | 0.41% |
388,303
-223,305
| -37% | -$1.13M |
|
30
Kyverna Therapeutics
KYTX
$160M
| $1.8M | 0.38% |
586,909
| – | – |
|
31
Disc Medicine
IRON
$2.07B
| $1.62M | 0.34% |
+30,661
| New | +$1.62M |
|
32
Fulcrum Therapeutics
FULC
$351M
| $1.3M | 0.27% |
188,304
-13,835
| -7% | -$95.2K |
|
|
BCAX
33
Bicara Therapeutics Inc. Common Stock
BCAX
$651M
| $909K | 0.19% |
+97,800
| New | +$909K |
|
34
Metagenomi
MGX
$65.3M
| $783K | 0.16% |
528,993
| – | – |
|
35
Karyopharm Therapeutics
KPTI
$58.8M
| $629K | 0.13% |
146,013
-9,609
| -6% | -$41.4K |
|
36
Hyperfine
HYPR
$97.4M
| $547K | 0.11% |
760,035
| – | – |
|
37
Mersana Therapeutics
MRSN
$36.5M
| $464K | 0.1% |
1,567,413
-137,623
| -8% | -$40.7K |
|
38
ATAI Life Sciences
ATAI
$984M
| $431K | 0.09% |
196,858
| – | – |
|
39
Fractyl Health
GUTS
$68.8M
| $347K | 0.07% |
214,236
| – | – |
|
40
Sensei Biotherapeutics
SNSE
$10.5M
| $126K | 0.03% |
14,718
-279,656
| -95% | -$2.4M |
|
41
Arcutis Biotherapeutics
ARQT
$1.86B
| – | – |
0
| – | – |
|
|
42
Becton Dickinson
BDX
$55.3B
| – | – |
-203,965
| Closed | -$46.7M |
|
|
43
Inspire Medical Systems
INSP
$2.77B
| – | – |
-85,877
| Closed | -$13.7M |
|
44
Keros Therapeutics
KROS
$618M
| – | – |
-389,384
| Closed | -$3.97M |
|
|
45
LivaNova
LIVN
$3.11B
| – | – |
-381,648
| Closed | -$15M |
|
46
Regeneron Pharmaceuticals
REGN
$61.5B
| – | – |
-12,261
| Closed | -$7.78M |
|
|
SWTX
47
DELISTED
SpringWorks Therapeutics
SWTX
| – | – |
-758,533
| Closed | -$33.5M |
|
|
48
Veracyte
VCYT
$2.39B
| – | – |
-762,225
| Closed | -$22.6M |
|